BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19421717)

  • 21. P53 codon 72 polymorphism and susceptibility to development of human papilloma virus-associated cervical cancer in Indian women.
    Nagpal JK; Sahni S; Das BR
    Eur J Clin Invest; 2002 Dec; 32(12):943-8. PubMed ID: 12534455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Global expression analysis in uterine cervical cancer: metabolic pathways and altered genes].
    Vázquez-Ortíz G; Piña-Sanchez P; Hidalgo A; Lazos M; Moreno J; Alvarado I; Cruz F; Hernández DM; Pérez-Plascencia C; Salcedo M
    Rev Invest Clin; 2005; 57(3):434-41. PubMed ID: 16187704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer.
    Burger RA; Monk BJ; Kurosaki T; Anton-Culver H; Vasilev SA; Berman ML; Wilczynski SP
    J Natl Cancer Inst; 1996 Oct; 88(19):1361-8. PubMed ID: 8827013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The degree of agreement between HPV testing, pap smear and colposcopy in cervical dysplasia diagnosis.
    Melinte-Popescu A; Costăchescu G
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):536-9. PubMed ID: 23077949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of interleukin-6/signal transducer and activator of transcription 3 by human papillomavirus early proteins 6 induces fibroblast senescence to promote cervical tumourigenesis through autocrine and paracrine pathways in tumour microenvironment.
    Ren C; Cheng X; Lu B; Yang G
    Eur J Cancer; 2013 Dec; 49(18):3889-99. PubMed ID: 23953057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Type-specific human papillomavirus distribution in invasive cervical cancer in Korea, 1958-2004.
    Oh JK; Alemany L; Suh JI; Rha SH; Muñoz N; Bosch FX; Quint W; Lloveras B; Klaustermeier JE; de Sanjosé S; Shin HR
    Asian Pac J Cancer Prev; 2010; 11(4):993-1000. PubMed ID: 21133613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clonal history of papillomavirus-induced dysplasia in the female lower genital tract.
    Vinokurova S; Wentzensen N; Einenkel J; Klaes R; Ziegert C; Melsheimer P; Sartor H; Horn LC; Höckel M; von Knebel Doeberitz M
    J Natl Cancer Inst; 2005 Dec; 97(24):1816-21. PubMed ID: 16368943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retrospective analysis of HPV 16/18-related disease burden using archival clinical samples.
    Ilahi NE; Hashmi SN; Anwar S; Murad S
    J Cancer Res Clin Oncol; 2016 Nov; 142(11):2367-73. PubMed ID: 27573495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic methods and techniques in cervical cancer prevention Part II: Molecular diagnostics of HPV infection.
    Vince A; Lepej SZ
    Med Glas (Zenica); 2010 Feb; 7(1):18-25. PubMed ID: 20387720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-risk HPV infection modulates the promoter hypermethylation of APC, SFRP1, and PTEN in cervical cancer patients of North India.
    Kadian LK; Yadav R; Nanda S; Gulshan G; Sharma S; Yadav C
    Mol Biol Rep; 2020 Dec; 47(12):9725-9732. PubMed ID: 33230782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and age-wise distribution of Human Papillomavirus type 16/18 infections among hospital screened women of a peri-urban area in West Bengal: Impact of socio-demographic factors.
    Bhattacharya A; Sen S; Mandal P; Sharma Saha S; Sarkar S; Pathak OP; Biswas L; Roy J; Banerjee R; Roy Chowdhury R; Pal M; Mukherjee A; Sengupta S
    Cancer Epidemiol; 2018 Jun; 54():31-37. PubMed ID: 29571035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-34a Inhibits Viability and Invasion of Human Papillomavirus-Positive Cervical Cancer Cells by Targeting E2F3 and Regulating Survivin.
    Geng D; Song X; Ning F; Song Q; Yin H
    Int J Gynecol Cancer; 2015 May; 25(4):707-13. PubMed ID: 25675046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Detection of human papillomavirus DNA in cervical cancer tissue by PCR and direct sequencing].
    Liu X; Liu GB; Pang ZJ; Xing FQ; Guo SQ; Ma WL; Zheng WL
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):201-3. PubMed ID: 15699006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nested multiplex PCR based detection of human papillomavirus in cervical carcinoma patients of North- East India.
    Das D; Rai AK; Kataki AC; Barmon D; Deka P; Sharma JD; Sarma A; Shrivastava S; Bhattacharyya M; Kalita AK; Sharma M; Ahmed S
    Asian Pac J Cancer Prev; 2013; 14(2):785-90. PubMed ID: 23621238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of human papillomavirus genotype among Moroccan women during a local screening program.
    Alhamany Z; El Mzibri M; Kharbach A; Malihy A; Abouqal R; Jaddi H; Benomar A; Attaleb M; Lamalmi N; Cherradi N
    J Infect Dev Ctries; 2010 Nov; 4(11):732-9. PubMed ID: 21252451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liquid biopsy of HPV DNA in cervical cancer.
    Cheung TH; Yim SF; Yu MY; Worley MJ; Fiascone SJ; Chiu RWK; Lo KWK; Siu NSS; Wong MCS; Yeung ACM; Wong RRY; Chen ZG; Elias KM; Chung TKH; Berkowitz RS; Wong YF; Chan PKS
    J Clin Virol; 2019 May; 114():32-36. PubMed ID: 30913520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human Papillomavirus DNA Methylation as a Biomarker for Cervical Precancer: Consistency across 12 Genotypes and Potential Impact on Management of HPV-Positive Women.
    Clarke MA; Gradissimo A; Schiffman M; Lam J; Sollecito CC; Fetterman B; Lorey T; Poitras N; Raine-Bennett TR; Castle PE; Wentzensen N; Burk RD
    Clin Cancer Res; 2018 May; 24(9):2194-2202. PubMed ID: 29420222
    [No Abstract]   [Full Text] [Related]  

  • 38. Correlation between cervical HPV DNA detection and HPV16 seroreactivity measured with L1-only and L1+L2 viral capsid antigens.
    Trevisan A; Candeias JMG; Thomann P; Villa LL; Franco EL; Trottier H; The Ludwig-McGill Study Group
    J Med Microbiol; 2020 Jul; 69(7):960-970. PubMed ID: 32510304
    [No Abstract]   [Full Text] [Related]  

  • 39. HPV status in sentinel nodes might be a prognostic factor in cervical cancer.
    Lee YS; Rhim CC; Lee HN; Lee KH; Park JS; Namkoong SE
    Gynecol Oncol; 2007 May; 105(2):351-7. PubMed ID: 17275890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Telomerase activation and human papillomavirus infection in invasive uterine cervical carcinoma in a set of Malaysian patients.
    Cheah PL; Looi LM; Ng MH; Sivanesaratnam V
    J Clin Pathol; 2002 Jan; 55(1):22-6. PubMed ID: 11825919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.